BOCA RATON, Fla.–(BUSINESS WIRE)–SurGenTec, a privately held medical device company focusing on spine and orthopedic technologies, proudly announces FDA clearance for TILINK-P, a first-of-its-kind, minimally-invasive implant that offers hope for individuals suffering from chronic sacroiliac (SI) joint pain.